XML 50 R38.htm IDEA: XBRL DOCUMENT v3.22.2
Investments in Equity Securities (Investment in JUUL Narrative) (Details)
shares in Millions, $ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Dec. 31, 2018
USD ($)
Jun. 30, 2022
USD ($)
director
shares
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
director
shares
Jun. 30, 2021
USD ($)
Apr. 30, 2020
Jan. 31, 2020
Schedule of Equity Method Investments [Line Items]              
Equity securities without readily determinable fair value, number of oversight committee chair directors designated by investor upon share conversion   1   1      
JUUL [Member]              
Schedule of Equity Method Investments [Line Items]              
Payments to acquire equity securities without readily determinable fair value | $ $ 12,800            
Equity securities, ownership percentage 35.00% 35.00%   35.00%   35.00%  
Equity investments, fair value option, voting shares (in shares) | shares   42   42      
Equity securities without readily determinable fair value, service agreement term       6 years      
Equity securities without readily determinable fair value, non-compete release trigger percentage of investment carrying value             10.00%
Equity securities without readily determinable fair value, quantitative assessment adjustment, annual amount | $ $ 12,800            
Equity securities without readily determinable fair value, amount | $   $ 450   $ 450      
Equity securities without readily determinable fair value, number of board members   7   7      
Equity securities without readily determinable fair value, number of board members upon share conversion   9   9      
Equity securities without readily determinable fair value, number of independent board members upon share conversion   3   3      
Equity securities without readily determinable fair value, number of board members appointed by investor upon share conversion       1      
Equity securities without readily determinable fair value, number of board members appointed by investee stockholders upon share conversion   2   2      
Equity securities without readily determinable fair value, number of investor nominating committee designees upon share conversion   1   1      
Equity securities without readily determinable fair value, number of directors designated by investor upon share conversion   2   2      
Equity securities without readily determinable fair value, number of nominating committee directors designated by investee upon share conversion   3   3      
Equity securities without readily determinable fair value, number of oversight committee directors designated by investor upon share conversion   2   2      
Income (loss) from equity investments, fair value option | $   $ (1,155) $ 100 $ (1,255) $ (100)